BiotechTube
Home/CARGO Therapeutics/Gina Chapman
GC

Gina Chapman

President, Chief Executive Officer, and Board Member

CARGO Therapeutics

Therapeutic Areas

OncologyHematology

CARGO Therapeutics Pipeline

DrugIndicationPhase
CRG-022Large B-cell lymphoma (LBCL) post-CD19 CAR T relapse/refractoryPhase 2

Leadership Team at CARGO Therapeutics

BH
Brett H. Hall, Ph.D.
Chief Scientific Officer
KM
Kristen M. Hege, M.D.
Senior Vice President, Early Clinical Development & Hematology/Oncology Therapy Area Lead
SA
Sunil Agarwal, M.D.
Senior Vice President, Clinical Development
JP
James P. Bock, M.B.A.
Chief Financial Officer
HC
Hannah Chang, J.D.
General Counsel
SK
Steve Krognes
Chairman of the Board of Directors
View full CARGO Therapeutics profile